Results 31 to 40 of about 291,938 (249)

A case–control study in France showing that a pro-inflammatory diet is associated with a higher risk of breast cancer

Scientific Reports, 2021
Dietary regimens promoting inflammatory conditions have been implicated in breast cancer development, but studies on the association between pro-inflammatory diet and breast cancer risk have reported inconsistent results.
Mariem Hajji-Louati, Emilie Cordina-Duverger, Nasser Laouali, Francesca-Romana Mancini, Pascal Guénel   +4 more
doaj   +1 more source

Metastatic cervical adenocarcinoma to the breast: A case report and literature review

Gynecologic Oncology Reports, 2019
Breast metastases from gynecologic cancers are rare. Cervical cancer most commonly metastasizes to the lung, liver or bone. When cervical cancer metastasizes to the breast, the presentation is usually a solitary breast mass; rarely, however, breast ...
Karen Cholmondeley, Laura Callan, Nikhil Sangle, David D'Souza   +3 more
doaj   +1 more source

Cumulative environmental quality is associated with breast cancer incidence differentially by summary stage and urbanicity

Scientific Reports, 2023
Individual environmental contaminants have been associated with breast cancer; however, evaluations of multiple exposures simultaneously are limited. Herein, we evaluated associations between breast cancer summary stages and the Environmental Quality ...
Larisa M. Gearhart-Serna, Brittany A. Mills, Hillary Hsu, Oluwadamilola M. Fayanju, Kate Hoffman, Gayathri R. Devi   +5 more
doaj   +1 more source

Peroxisome proliferator activated receptor-α/hypoxia inducible factor-1α interplay sustains carbonic anhydrase IX and apoliprotein E expression in breast cancer stem cells. [PDF]

PLoS ONE, 2013
AIMS: Cancer stem cell biology is tightly connected to the regulation of the pro-inflammatory cytokine network. The concept of cancer stem cells "inflammatory addiction" leads to envisage the potential role of anti-inflammatory molecules as new anti ...
Alessio Papi, Gianluca Storci, Tiziana Guarnieri, Sabrina De Carolis, Sara Bertoni, Nicola Avenia, Alessandro Sanguinetti, Angelo Sidoni, Donatella Santini, Claudio Ceccarelli, Mario Taffurelli, Marina Orlandi, Massimiliano Bonafé   +12 more
doaj   +1 more source

An epithelial GPR35 isoform supports tumor‐associated transcriptional and metabolic phenotypes

FEBS Letters, EarlyView.
GPR35 generates two functionally distinct isoforms with previously unresolved roles. GPR35‐short mediates immune‐cell chemotaxis, while GPR35‐long is enriched in colorectal cancer epithelium, where it supports increased metabolism, proliferation, and tumor‐associated transcriptional programs.
Jørgen D. Rønneberg, Martine Hjeltnes, Josephine Krieger, Joshua E. Elias, Maria Stensland, Kristian Holm, Xiaojun Jiang, Chuki Khangsar, Tuula A. Nyman, Arthur Kaser, Johannes R. Hov, Tom H. Karlsen, Nicole C. Kaneider, Frode L. Jahnsen, Georg Schneditz   +14 more
wiley   +1 more source

Hijacking emergency granulopoiesis: Neutrophil ontogeny and reprogramming in cancer

Molecular Oncology, EarlyView.
Neutrophils are highly plastic innate immune cells; their functions in cancer extend beyond the tumour microenvironment. This Review summarises current understanding of neutrophil maturation and heterogeneity and highlights tumour‐induced granulopoiesis as a systemic programme that expands immature, immunosuppressive neutrophils via tumour‐derived ...
Gabriela Marinescu, Yi Feng
wiley   +1 more source

Metastasis on pause: How dormant tumor cells stay hidden within the tumor microenvironment and evade immune surveillance

Molecular Oncology, EarlyView.
Dormant cancer cells can hide in distant organs for years, evading treatment and the immune system. This review highlights how signals from the surrounding tissue and immune environment keep these cells inactive or trigger their reawakening. Understanding these mechanisms may help develop therapies to eliminate or control dormant cells and prevent ...
Kanishka Tiwary, Jose Javier Bravo‐Cordero   +1 more
wiley   +1 more source

An update on inflammatory breast cancer

Oncology Reviews, 2011
Inflammatory breast cancer is one of the most aggressive forms of breast cancer. Once considered to be a uniformly fatal disease, treatment of this entity has evolved significantly over the last two decades.
P. Thapaliya, N. J. Karlin
doaj   +1 more source

Blockade of store-operated calcium entry sensitizes breast cancer cells to cisplatin therapy via modulating inflammatory response

Saudi Pharmaceutical Journal, 2023
Store-operated calcium entry (SOCE) is an important pathway for calcium signaling that regulates calcium influx across the plasma membrane upon the depletion of calcium stores in the endoplasmic reticulum.
Abdullah S. Alhamed, Mohammed Alqinyah, Musab A. Alsufayan, Ibrahim A. Alhaydan, Yasseen A. Alassmrry, Hajar O. Alnefaie, Mohammad M. Algahtani, Adel F. Alghaith, Hussain N. Alhamami, Abdullah M. Albogami, Khalid Alhazzani, Alanazi AZ   +11 more
doaj   +1 more source

Inflammatory breast cancer-importance of breast imaging

European Journal of Surgical Oncology, 2018
Inflammatory breast cancer (IBC) is a rare form of primary cancer and accounts for only 1-5 % of all breast cancer types.[1–3] It is classified as T4d stage by TNM classification,[4] the most aggressive form of breast cancer with a 20%–30% incidence of distant metastasis at the time of diagnosis[5] and poorer prognosis than the non-IBC locally advanced
Papalouka, Vasiliki, Gilbert, Fiona J
openaire   +3 more sources